Analysis of MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) by histology and specific mutation | Caris Life Sciences
Portal
Order
Home / Research / Publications / Analysis of MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) by histology and specific mutation

Publications

Back

Analysis of MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) by histology and specific mutation

– Caris Life Sciences

Poster

Key Finding:

MET exon 14 skipping occurs in both squamous and non-squamous non-small cell lung cancer and there is heterogeneity in co-mutations, tumor mutational burden, and PD-L1 expression within different types of MET exon 14 skipping mutations.

Download Publication

Discover
More

  • Spliceosome Mutations in Metastatic Breast Cancer An Analysis of a Decentralized Clinical Trial and Large Clinical Genomic Dataset

    – Caris Life Sciences

    Poster

    […]

  • Molecular landscape of HR+/HER2- male breast cancer (MaBC) compared with female breast cancer (FeBC)

    – Caris Life Sciences

    Poster

    […]
Learn More

Ready to Get Started on the Journey?

Name(Required)